In recent trading session, Gilead Sciences, Inc. (NASDAQ:GILD) saw 2.79 million shares changing hands at last check today with its beta currently measuring 0.20. Company’s recent per share price level of $78.68 trading at -$0.09 or -0.11% at last check today assigns it a market valuation of $97.96B. That most recent trading price of GILD’s stock is at a discount of -11.67% from its 52-week high price of $87.86 and is indicating a premium of 21.11% from its 52-week low price of $62.07. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 5.52 million shares which gives us an average trading volume of 6.95 million if we extend that period to 3-months.
For Gilead Sciences, Inc. (GILD), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 2.17. Splitting up the data highlights that, out of 17 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 6 suggested the stock as a Hold whereas 11 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of 1.59 in the current quarter.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Gilead Sciences, Inc. (NASDAQ:GILD) trade information
Upright in the red during last session for losing -0.11%, in the last five days GILD remained trading in the red while hitting it’s week-highest on Tuesday, 09/03/24 when the stock touched $78.68 price level, adding 2.18% to its value on the day. Gilead Sciences, Inc.’s shares saw a change of -2.88% in year-to-date performance and have moved -0.97% in past 5-day. Gilead Sciences, Inc. (NASDAQ:GILD) showed a performance of 6.32% in past 30-days. Number of shares sold short was 16.77 million shares which calculate 2.61 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 82 to the stock, which implies a rise of 4.05% to its recent value today. Analysts have been projecting 54 as a low price target for the stock while placing it at a high target of 112. It follows that stock’s current price would jump 31.37% in reaching the projected high whereas dropping to the targeted low would mean a gain of 31.37% for stock’s current value.
Gilead Sciences, Inc. (GILD) estimates and forecasts
Statistics highlight that Gilead Sciences, Inc. is scoring comparatively lower than the scores of other players of the relevant industry. The company added 6.82% of value to its shares in past 6 months, showing an annual growth rate of -43.75% while that of industry is 17.90. Apart from that, the company came lowering its revenue forecast for fiscal year 2024. This year revenue growth is estimated to rise 9.40% from the last financial year’s standing.
18 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 6.97B for the same. And 17 analysts are in estimates of company making revenue of 7.14B in the next quarter. Company posted 6.8B and 6.65B of sales in current and next quarters respectively a year earlier.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 1.55% during past 5 years. In 2024, company’s earnings growth rate is likely to be around -43.67% while estimates for its earnings growth in next 5 years are of 5.98%.
GILD Dividends
Gilead Sciences, Inc. is more likely to be releasing its next quarterly report on 2024-Nov-07 and investors are confident in the company announcing better current-quarter dividends despite the fact that it has been facing issues arising out of mounting debt. With an annual yield of 3.86%, the share has a forward dividend of 3.04 which implies that company’s dividend yield remained growing in trailing twelve months while having a 5 year average dividend yield of 4.03%.
Gilead Sciences, Inc. (NASDAQ:GILD)’s Major holders
Insiders are in possession of 0.12% of company’s total shares while institution are holding 87.91 percent of that, with stock having share float percentage of 88.02%. Investors also watch the number of corporate investors in a company very closely, which is 87.91% institutions for Gilead Sciences, Inc. that are currently holding shares of the company. BLACKROCK INC. is the top institutional holder at GILD for having 120.63 million shares of worth $8.28 billion. And as of 2024-06-30, it was holding 9.6738 of the company’s outstanding shares.
The second largest institutional holder is VANGUARD GROUP INC, which was holding about 115.26 million shares on 2024-06-30. The number of shares represents firm’s hold over 9.2431 of outstanding shares, having a total worth of $7.91 billion.
